Aphthous-Like Stomatitis in a Patient Receiving Panitumumab
Anti-epithelial growth factor receptor agents are associated with oral adverse events that may cause severe pain, even necessitating discontinuation of the antineoplastic treatment. The implementation of preventive measures, early diagnosis, proper treatment and close monitoring of patients receiving anti-epithelial growth factor receptor agents are mandatory in order to preserve patients' quality of life and their compliance to therapeutic regimen.
Authors
- Evangelia Piperi (ORCID: https://orcid.org/0000-0001-5389-1837)
- Maria Kouri (ORCID: https://orcid.org/0000-0002-0009-4911)
- Maria Georgaki (ORCID: https://orcid.org/0000-0002-0734-8857)
- Dimitrios Velonis
- Nikolaos G. Nikitakis
- E. Papadopoulou (ORCID: https://orcid.org/0000-0003-2227-0127)
- Emmanouil Vardas (ORCID: https://orcid.org/0000-0001-9803-2702)
- Styliani Tziveleka
Institutions
- National and Kapodistrian University of Athens (GR)
Publication Details
- Journal
- Journal of Oral and Maxillofacial Research
- Published
- 2024-12-31
- DOI
- https://doi.org/10.5037/jomr.2024.15405
- Primary Topic
- Oral Health Pathology and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00